The global brachioplasty market accounted for USD 1.46 billion in 2023 and is expected to reach at USD 3.13 billion by 2034 with a CAGR of 7.18% during the forecast period 2024-2034. Rise in weight loss surgeries, increasing emphasis on self-esteem, growing advancements in both surgical & non-surgical techniques, surge in aging population, rising obesity rates, increasing adoption of cosmetic surgeries, growing technological advancements, surge in introduction of advanced surgical devices, and increase in regulatory approvals for innovative devices used in brachioplasty are some of the key factors boosting the market growth.
Increase in regulatory approvals for innovative devices used in brachioplasty is predicted to boost the market growth during the forecast period. Brachioplasty, commonly referred to as an arm lift, is a surgical intervention aimed at enhancing the aesthetic appearance of the upper arm by eliminating surplus fat and tissue from the back portion. For instance, in March 2023, Sentient, LLC has obtained approval from the U.S. FDA for its product, Sentient Sculpt, which utilizes non-invasive electromagnetic wave therapy to reduce cellulite.
By procedure, surgical was the highest revenue-grossing segment in the global brachioplasty market in 2023 owing to the rising interest in the effectiveness & durability of surgical brachioplasty procedures, as supported by established medical literature regarding long-term contour maintenance, increasing demand for minimally invasive surgical devices, and growing number of approvals from regulatory agencies. For instance, in December 2023, Sofwave Medical Ltd has received clearance from the U.S. Food and Drug Administration (FDA) for its 510(k) premarket notification submission, allowing the company to enhance the appearance of skin laxity on the upper arms. This clearance also enables Sofwave to pursue additional treatment indications for expansion. Additionally, non-surgical segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing technological advancements in energy-based devices, focusing on tightening upper arm tissues and diminishing cellulite.
By end-user, cosmetic surgery clinics was the highest revenue-grossing segment in the global brachioplasty market in 2023. Clinics specializing in aesthetics and beauty are increasingly prioritizing personalized care, resulting in shorter waiting times and reduced risk of sickness and infection. Long-term patient trial data consistently validate the safety of these centers. Moreover, growing trend towards the introduction of technologically advanced clinics and increase in the launch of sophisticated devices. For instance, in February 2023, Oleeva Fabric, tailored into Jobskin Oleeva Brachioplasty forms, has been introduced for specialized scar management following arm lift surgery. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to their renowned reputation, state-of-the-art facilities, and expertise in managing complex cases, hospitals are often favored by patients with extensive medical backgrounds or those undergoing combined procedures like post-bariatric brachioplasty. Hospitals offer comprehensive care and may attract a wider range of patients due to their association with mainstream healthcare, making them a preferred choice for individuals seeking brachioplasty procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in the acceptance of cosmetic surgeries, growing advancements in both surgical & non-surgical techniques, growing number of weight-loss surgeries, and uptick in regulatory approvals for innovative devices. For instance, in January 2023, The FDA has granted clearance to Apyx Medical for the updated Apyx One Console, allowing its use in cosmetic surgical procedures within the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising significance of physical appearance, increasing integration of social media, surge in the development of healthcare infrastructure, the availability of advanced products & technologies, regulatory authorities are increasingly granting approvals. For instance, in November 2023, Revelle Aesthetics, a FemTech company based in Silicon Valley and backed by venture capital, revealed that its Avéli device, which is cleared by the US FDA for long-term reduction of cellulite appearance, has obtained its inaugural international clearance in Australia. Australia is identified as one of the most significant market prospects for cellulite treatment beyond the United States.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increase in regulatory approvals for innovative devices used in brachioplasty is predicted to boost the market growth during the forecast period. Brachioplasty, commonly referred to as an arm lift, is a surgical intervention aimed at enhancing the aesthetic appearance of the upper arm by eliminating surplus fat and tissue from the back portion. For instance, in March 2023, Sentient, LLC has obtained approval from the U.S. FDA for its product, Sentient Sculpt, which utilizes non-invasive electromagnetic wave therapy to reduce cellulite.
By procedure, surgical was the highest revenue-grossing segment in the global brachioplasty market in 2023 owing to the rising interest in the effectiveness & durability of surgical brachioplasty procedures, as supported by established medical literature regarding long-term contour maintenance, increasing demand for minimally invasive surgical devices, and growing number of approvals from regulatory agencies. For instance, in December 2023, Sofwave Medical Ltd has received clearance from the U.S. Food and Drug Administration (FDA) for its 510(k) premarket notification submission, allowing the company to enhance the appearance of skin laxity on the upper arms. This clearance also enables Sofwave to pursue additional treatment indications for expansion. Additionally, non-surgical segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing technological advancements in energy-based devices, focusing on tightening upper arm tissues and diminishing cellulite.
By end-user, cosmetic surgery clinics was the highest revenue-grossing segment in the global brachioplasty market in 2023. Clinics specializing in aesthetics and beauty are increasingly prioritizing personalized care, resulting in shorter waiting times and reduced risk of sickness and infection. Long-term patient trial data consistently validate the safety of these centers. Moreover, growing trend towards the introduction of technologically advanced clinics and increase in the launch of sophisticated devices. For instance, in February 2023, Oleeva Fabric, tailored into Jobskin Oleeva Brachioplasty forms, has been introduced for specialized scar management following arm lift surgery. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to their renowned reputation, state-of-the-art facilities, and expertise in managing complex cases, hospitals are often favored by patients with extensive medical backgrounds or those undergoing combined procedures like post-bariatric brachioplasty. Hospitals offer comprehensive care and may attract a wider range of patients due to their association with mainstream healthcare, making them a preferred choice for individuals seeking brachioplasty procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in the acceptance of cosmetic surgeries, growing advancements in both surgical & non-surgical techniques, growing number of weight-loss surgeries, and uptick in regulatory approvals for innovative devices. For instance, in January 2023, The FDA has granted clearance to Apyx Medical for the updated Apyx One Console, allowing its use in cosmetic surgical procedures within the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising significance of physical appearance, increasing integration of social media, surge in the development of healthcare infrastructure, the availability of advanced products & technologies, regulatory authorities are increasingly granting approvals. For instance, in November 2023, Revelle Aesthetics, a FemTech company based in Silicon Valley and backed by venture capital, revealed that its Avéli device, which is cleared by the US FDA for long-term reduction of cellulite appearance, has obtained its inaugural international clearance in Australia. Australia is identified as one of the most significant market prospects for cellulite treatment beyond the United States.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Procedure and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Brachioplasty Market Report 2023 - 2034
Brachioplasty Market Analysis & Forecast by Procedure 2023 - 2034 (Revenue USD Bn)
- Non-Surgical
- Surgical
Brachioplasty Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Cosmetic Surgery Clinics
- Hospitals
Brachioplasty Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Brachioplasty Market: Procedure Estimates & Trend Analysis
8. Brachioplasty Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Brachioplasty Market
11. Europe Global Brachioplasty Market
12. Asia Pacific Global Brachioplasty Market
13. Latin America Global Brachioplasty Market
14. MEA Global Brachioplasty Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Westlake Dermatology & Cosmetic Surgery
- Nazarian Plastic Surgery.
- UK Healthcare Aesthetics Center
- B. Care Medical Center
- New York Plastic Surgical Group
- UK Aesthetic
- Marroquin & Sandoval Plastic Surgery
- Cadogan Clinics
- Ruby Surgery & Aesthetics
- Centre For Surgery
